TLR3_rs3775291 may also have clinical importance, since TLR3 agonists have been implemented as adjuvant therapy in clinical trials for different types of cancer and therapeutic response may depend on TLR3 status of the tumor tissue (Laplanche et al. 2000; Salaun et al. 2007). This evidence concerns the gene TLR3 and cancer.